✓ Plata cu cardul restabilită — finalizare securizată prin Privacy Shield

Hepcinat LP

✅ Treats Hepatitis C
✅ High success rate
✅ Shortens treatment duration
✅ Lowers risk of liver damage
✅ Improves liver function

Hepcinat LP contains Ledipasvir + Sofosbuvir.

Verificat medical de Morgan Ellis — Cercetător farmaceutic · 8 ani de experiență  · Ultima recenzie: mai 2026

Cumpără mai mult, economisește mai mult Preț pe tabletă
28 comprimate
US$18.36/tablet
US$514.00
56 comprimate
US$17.84/tablet · economisiți 3%
US$999.00
84 comprimate
US$17.00/tablet · economisește 7%
US$1,428.00
Plată criptată
Plățile în crypto reduc prețul cu 10%
Livrare discretă în întreaga lume
1.400+ clienți · 50+ țări

Quick Answer — Hepcinat LP (Sofosbuvir 400 mg + Ledipasvir 90 mg)

  • Active ingredients: sofosbuvir 400 mg + ledipasvir 90 mg, fixed-dose combination tablet, taken once daily.
  • Indication: chronic hepatitis C virus (HCV) infection, genotypes 1, 4, 5 and 6 in adults — the generic of Harvoni (Gilead).
  • Mechanism: sofosbuvir is an NS5B nucleotide polymerase inhibitor; ledipasvir is an NS5A inhibitor. The combination targets two essential HCV proteins simultaneously.
  • Cure rate: 94–99% sustained virologic response (SVR12) across most regimens — functional HCV cure in 12 weeks for treatment-naive non-cirrhotic patients.
  • Treatment is curative, not chronic suppression. Once SVR12 is achieved (HCV RNA undetectable 12 weeks post-treatment), HCV is eradicated and tablets stop.
  • Take with care alongside: amiodarone (bradycardia risk — usually contraindicated), strong CYP/P-gp inducers (rifampicin, St John’s wort, anticonvulsants — reduce DAA exposure), and acid-reducers (PPIs — lower ledipasvir absorption; separate by >= 12 hours where possible).
Ce beneficii oferă MedsBase: Producător certificat WHO-GMP · Ambalaj discret · Livrare la nivel mondial · Peste 1.400 de recenzii verificate ale clienților

📦 Fiecare comandă este acoperită de politica noastră de Politica noastră de Reexpediere Garantată — dacă coletul dumneavoastră nu sosește în 20 de zile lucrătoare, îl relivrăm.

De ce să comanzi de la MedsBase

Medicamentele noastre generice sunt procurate de la producători certificați WHO-GMP și expediate la nivel mondial în ambalaje discrete și simple — fără denumirea medicamentului pe exteriorul coletului. Plățile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de plăți cu card reglementat — niciodată “MedsBase” sau numele vreunui medicament). Acceptăm și criptomonede și transferuri bancare SEPA. Fiecare comandă este susținută de Politica noastră de Asigurare pentru Relivrare.

What Is Hepcinat LP?

Hepcinat LP is a fixed-dose combination tablet containing Ledipasvir 90 mg și Sofosbuvir 400 mg, manufactured by Natco Pharma — one of India’s largest specialty pharmaceutical companies. It is a direct-acting antiviral (DAA) treatment for chronic hepatitis C virus (HCV) infection, offering cure rates exceeding 95% in most patient populations.

Hepcinat LP is a generic equivalent of Harvoni (Gilead Sciences), which revolutionized hepatitis C treatment when it launched in 2014 at a cost of $94,500 per course in the United States. Hepcinat LP delivers the same clinical outcomes at a fraction of the cost, making a hepatitis C cure accessible to patients worldwide.

What Does Hepcinat LP Treat?

Hepcinat LP is approved for the treatment of chronic hepatitis C in adults with the following genotypes:

HCV GenotypeTreatment DurationCure Rate (SVR12)Note
Genotype 112 weeks (8 weeks in select patients)97–99%Most common genotype in the US and Europe
Genotype 412 săptămâni93–95%Common in Egypt and the Middle East
Genotype 512 săptămâni95%+Primarily found in South Africa
Genotype 612 săptămâni96%+Common in Southeast Asia

8-week treatment may be sufficient for treatment-naive genotype 1 patients without cirrhosis and with a baseline HCV RNA level below 6 million IU/mL.

For genotypes 2 and 3, a Sofosbuvir + Velpatasvir combination such as Velasof sau Velpanat is recommended instead, as these cover all HCV genotypes.

How Hepcinat LP Works

Hepcinat LP combines two direct-acting antivirals that target different stages of the hepatitis C replication cycle:

  • Sofosbuvir (400 mg) — A nucleotide analog NS5B polymerase inhibitor. It gets incorporated into the viral RNA chain during replication, causing premature chain termination. This blocks the virus from copying itself.
  • Ledipasvir (90 mg) — An NS5A inhibitor that blocks a protein essential for both viral replication and assembly of new virus particles. By targeting NS5A, Ledipasvir prevents the virus from multiplying and releasing new copies into the bloodstream.

By attacking HCV at two different points simultaneously, Hepcinat LP achieves rapid viral suppression and prevents the development of drug-resistant strains — a problem that plagued earlier single-agent hepatitis C treatments.

Dosage and How to Take Hepcinat LP

  • Luați one tablet once daily, with or without food.
  • Swallow the tablet whole with water — do not crush, break, or chew.
  • Take Hepcinat LP at the same time each day for consistent drug levels.
  • If you miss a dose, take it as soon as you remember on the same day. If it is already the next day, skip the missed dose and continue with your regular schedule.
  • Do not stop treatment early, even if you feel well. Completing the full course is essential to prevent viral relapse.

Treatment Duration

Patient TypeDuratăTablets NeededPrice at MedsBase
Treatment-naive, no cirrhosis, low viral load8 weeks56 tablets (2 packs)$999
Treatment-naive, no cirrhosis12 săptămâni84 tablets (3 packs)$1,428
Treatment-naive with compensated cirrhosis12 săptămâni84 tablets$1,428
Treatment-experienced, no cirrhosis12 săptămâni84 tablets$1,428
Treatment-experienced with compensated cirrhosis24 weeks168 tablets (6 packs)Contact us

What Is SVR12 (Sustained Virologic Response)?

SVR12 means the hepatitis C virus is undetectable in your blood 12 weeks after completing treatment. Achieving SVR12 is considered a functional cure — over 99% of patients who reach SVR12 remain virus-free permanently. Your doctor will order a blood test (HCV RNA PCR) at 12 weeks post-treatment to confirm cure.

Efecte Secundare

Hepcinat LP is one of the best-tolerated hepatitis C treatments available. Most patients complete the full course with minimal or no side effects.

Efecte Secundare Comune

  • Fatigue (reported in ~15% of patients)
  • Headache (~11%)
  • Nausea (~7%)
  • Insomnia
  • Diarrhea

These are generally mild and do not require treatment discontinuation.

Serious Side Effects (Rare)

  • Bradycardia (slow heart rate) — Reported when taken with amiodarone. This combination is contraindicated.
  • Hepatitis B reactivation — Patients co-infected with HBV must be monitored, as suppressing HCV can trigger HBV flare-ups.

Important Drug Interactions

  • Amiodarone — Do NOT take with Hepcinat LP. Can cause life-threatening bradycardia.
  • Rifampin, carbamazepine, phenytoin, St. John’s wort — Strong P-gp inducers that significantly reduce Sofosbuvir and Ledipasvir levels, potentially causing treatment failure.
  • Proton pump inhibitors (omeprazole, esomeprazole) — Reduce Ledipasvir absorption. If necessary, take a PPI at a dose not exceeding 20 mg, at least 2 hours before Hepcinat LP.
  • Antacids (Tums, Maalox) — Separate by at least 4 hours from Hepcinat LP.
  • Rosuvastatin — Levels may increase; limit to 10 mg/day.
  • HIV antiretrovirals — Tenofovir levels may increase when combined with certain HIV regimens. Renal monitoring is recommended. Products like Tenvir AF (TAF-based) are preferred over TDF-based regimens.

Avertismente și precauții

  • Hepatitis B co-infection: All patients should be tested for HBV before starting treatment. HBV reactivation can cause serious liver injury or death.
  • Decompensated cirrhosis: Hepcinat LP is not recommended for patients with decompensated liver disease (Child-Pugh B or C). A regimen containing Sofosbuvir + Velpatasvir + Voxilaprevir may be considered instead.
  • Kidney impairment: No dose adjustment needed for mild to moderate kidney impairment. Not recommended for severe renal impairment (eGFR < 30 mL/min).
  • Pregnancy: Not enough data to confirm safety. Avoid unless clearly necessary.

Hepcinat LP vs Other Hepatitis C Treatments

MedsBase offers several hepatitis C medications. Here’s how they compare:

ProdusActive IngredientsGenotypes CoveredPrice (12-week course)
Hepcinat LPLedipasvir 90 mg + Sofosbuvir 400 mg1, 4, 5, 6$1,428
LedifosLedipasvir 90 mg + Sofosbuvir 400 mg1, 4, 5, 6Check price
Hepcvir LLedipasvir 90 mg + Sofosbuvir 400 mg1, 4, 5, 6Check price
MyHep LVIRLedipasvir 90 mg + Sofosbuvir 400 mg1, 4, 5, 6Check price
VelasofVelpatasvir 100 mg + Sofosbuvir 400 mgAll (1–6)Check price
VelpanatVelpatasvir 100 mg + Sofosbuvir 400 mgAll (1–6)Check price
MyHep AllVelpatasvir 100 mg + Sofosbuvir 400 mgAll (1–6)Check price

Which should you choose? If you know your HCV genotype is 1, 4, 5, or 6, Hepcinat LP is a proven and cost-effective choice. If you are unsure of your genotype, a pan-genotypic option like Velasof sau Velpanat covers all genotypes and eliminates the need for genotyping tests.

Depozitare

Store at room temperature (20–25°C / 68–77°F). Protect from moisture and direct sunlight. Keep out of reach of children. Do not use after the expiration date on the packaging.

Întrebări frecvente

What is the cure rate of Hepcinat LP?

Clinical trials and real-world studies show cure rates (SVR12) of 95–99% for hepatitis C genotype 1 patients. Cure rates for genotypes 4, 5, and 6 are similarly high, typically exceeding 93%.

Is Hepcinat LP the same as Harvoni?

Yes. Hepcinat LP is a generic version of Harvoni, containing the same active ingredients (Ledipasvir 90 mg + Sofosbuvir 400 mg) in the same doses. It is manufactured by Natco Pharma under a voluntary license from Gilead Sciences and is bioequivalent to the branded product.

How long do I need to take Hepcinat LP?

Most patients take Hepcinat LP for 12 weeks (84 days). Some treatment-naive patients without cirrhosis and with low viral loads may qualify for an 8-week course. Treatment-experienced patients with cirrhosis may need 24 weeks. Your doctor will determine the appropriate duration.

Can Hepcinat LP cure all types of hepatitis C?

Hepcinat LP is most effective for HCV genotypes 1, 4, 5, and 6. For genotypes 2 and 3, a Sofosbuvir + Velpatasvir combination (such as Velasof) is recommended instead.

What tests do I need before starting Hepcinat LP?

Before starting treatment, your doctor should order: HCV genotype test, HCV viral load (RNA PCR), hepatitis B surface antigen test, liver function tests, and a kidney function test (eGFR). If cirrhosis is suspected, a FibroScan or liver biopsy may be recommended.

Can I take Hepcinat LP if I have cirrhosis?

Yes — Hepcinat LP is effective for patients with compensated cirrhosis (Child-Pugh A). A 12-week course is recommended. However, it is not recommended for decompensated cirrhosis (Child-Pugh B or C), which requires specialist management.

Can I take Hepcinat LP with HIV medications?

Hepcinat LP can be used with most HIV antiretroviral regimens. However, Tenofovir disoproxil fumarate (TDF) levels may increase when combined with Ledipasvir, so renal function should be monitored. TAF-based regimens such as Tenvir AF are generally preferred.

Do I need a prescription to buy Hepcinat LP?

At MedsBase, you can order Hepcinat LP online without a prescription. We offer discreet packaging and worldwide shipping. We strongly recommend consulting a hepatologist or gastroenterologist before starting treatment to determine the correct duration and monitor your response.

Declinare de responsabilitate

Singura noastră intenție este să ne asigurăm că consumatorii noștri primesc informații verificate de experți, exacte și de încredere. Cu toate acestea, informațiile conținute aici NU trebuie utilizate ca înlocuitor pentru sfatul unui medic calificat. Informațiile furnizate aici au scop pur informativ. Acestea pot să nu acopere toate posibilele efecte secundare, interacțiuni medicamentoase sau avertismente. Vă rugăm să consultați medicul dumneavoastră și să discutați toate întrebările legate de orice boală sau medicament. Intenția noastră este de a sprijini, nu de a înlocui relația medic-pacient.

Alternative conexe

Alte produse din Afecțiuni cronice pe care clienții le vizualizează de asemenea:

More options in Hepatitis Medication

Clasificate în funcție de volumul recent de comenzi MedsBase — ce aleg alți clienți în această categorie.

Concentrație

90 mg + 400 mg

Cantitate

28 Tablet/s, 56 Tablet/s, 84 Tablet/s

Formă farmaceutică

Comprimat/e

Producător

Natco Pharma

Indicație

Hepatitis C

Brand generic

Ledipasvir & Sofosbuvir

Recenzii

Nu există recenzii încă

Adăugați o recenzie
Hepcinat LP Hepcinat LP
Evaluare*
0/5
* Evaluarea este obligatorie
* Răspunsul este obligatoriu
Recenzia dvs.
* Recenzia este obligatorie
Nume
* Numele este obligatoriu
Adăugați fotografii sau videoclip la recenzia dvs.

Întrebări și răspunsuri

Pune o întrebare
Hepcinat LP Hepcinat LP
Întrebarea ta
* Întrebarea este obligatorie
Nume
* Numele este obligatoriu
Nu există întrebări încă